[Ceftriaxone, a long-acting cephalosporin. Microbiological, kinetic and clinical study]

Minerva Med. 1983 Sep 22;74(36):2093-102.
[Article in Italian]

Abstract

Ceftriaxone effectively inhibited 332 out of 452 (73.45%) bacterial strains in vitro tests. 291 out of 365 (79.69%) gram negative and 41 out of 87 (47.12%) gram positive strains were inhibited. The tests showed ceftriaxone to be more effective than cephalothin, cephotaxime, cephuroxime, cephamandol and cephoxitin. Kinetic tests showed that cephtriaxone has a plasmatic half life of 7.25 hrs. 24 hours after administration of a 1000 mg venous bolus the drug was still present in the blood. Urinary elimination over a 24 hr. period amounted to means 486.8 mg (48.68%). The drug has liquor transfer capacity. 37 of the 38 patients treated showed complete clinical or clinicobacteriological cure. Improvement was noted in the 38th.

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cefotaxime / analogs & derivatives*
  • Cefotaxime / metabolism
  • Cefotaxime / therapeutic use
  • Ceftriaxone
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Female
  • Gram-Negative Bacteria / drug effects
  • Gram-Positive Bacteria / drug effects
  • Half-Life
  • Humans
  • Kinetics
  • Klebsiella Infections / drug therapy
  • Male
  • Meningitis / drug therapy
  • Middle Aged
  • Respiratory Tract Infections / drug therapy
  • Staphylococcal Infections / drug therapy
  • Streptococcal Infections / drug therapy

Substances

  • Ceftriaxone
  • Cefotaxime